GROUP ONE TRADING, L.P. - PROTALIX BIOTHERAPEUTICS INC ownership

PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A101. A total of 44 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is 282.07 and the average weighting 0.2%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of PROTALIX BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2019$47,000
-55.2%
227,797
+2.2%
0.00%
-100.0%
Q2 2019$105,000
+483.3%
222,886
+434.4%
0.00%
Q1 2019$18,000
+157.1%
41,706
+76.7%
0.00%
Q4 2018$7,000
-75.0%
23,606
-38.5%
0.00%
Q3 2018$28,00038,356
+10379.8%
0.00%
Q3 2016$03660.0%0.00%
Q2 2016$03660.0%0.00%
Q1 2016$0
-100.0%
366
-97.1%
0.00%
Q2 2015$25,000
-43.2%
12,723
-48.1%
0.00%
-100.0%
Q1 2015$44,000
+25.7%
24,528
+30.1%
0.00%0.0%
Q4 2014$35,000
-86.6%
18,849
-82.5%
0.00%
-75.0%
Q3 2014$261,000
-52.6%
107,917
-28.6%
0.00%
-50.0%
Q2 2014$551,000
+60.6%
151,046
+101.9%
0.01%
+33.3%
Q1 2014$343,000
+94.9%
74,808
+65.1%
0.01%
+100.0%
Q4 2013$176,000
-38.7%
45,315
-28.5%
0.00%
-40.0%
Q3 2013$287,000
+156.2%
63,357
+176.9%
0.01%
+66.7%
Q2 2013$112,00022,8780.00%
Other shareholders
PROTALIX BIOTHERAPEUTICS INC shareholders Q4 2013
NameSharesValueWeighting ↓
Opaleye Management Inc. 1,825,000$1,206,0000.39%
Zhang Financial LLC 45,000$33,0000.02%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 472,553$313,0000.01%
MEITAV INVESTMENT HOUSE LTD 127,062$85,0000.01%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 324,479$215,000,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 302,588$200,0000.00%
Renaissance Technologies 1,993,500$1,318,0000.00%
WEDBUSH SECURITIES INC 15,000$10,0000.00%
TWO SIGMA SECURITIES, LLC 57,127$38,0000.00%
Psagot Value Holdings Ltd. 29,193$20,0000.00%
View complete list of PROTALIX BIOTHERAPEUTICS INC shareholders